PATENT CLAIM ANALYSIS

Application Number: 15903764
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["514", "002900"]

Abstract:
Lyophilized daptomycin formulations having improved reconstitution times are provided. The lyophilized daptomycin formulations include an additive, which can be a pharmaceutically acceptable antioxidant, a pharmaceutically acceptable organic acid or a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable glucose derivative or a pharmaceutically acceptable salt thereof, or a combination thereof. Also provided are methods of methods of preparing the lyophilized daptomycin formulations, and methods of treating bacterial infections and treating or preventing biofilms by using the lyophilized daptomycin formulations.

Claim (Index 28):
A reconstituted daptomycin formulation according to  claim 27 , wherein the volume of the pharmaceutically acceptable diluent is from about 5 mL to about 15 mL.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.95455
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14427618', '14824272', '14096346', '15400791', '12374489']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7812608546043451
- 35 USC 102 Novelty (BERT): 0.5753018731187721
- Combined Prediction Score: 0.7606649564557878
- Mean Citation Score: 332.452106
- Max Citation Score: 502.24286
- Similarity Product: 348.64836144812705

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test